Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-catechin | multiple interactions | ISO | RPL30 (Homo sapiens) | 6480464 | [Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of RPL30 mRNA | CTD | PMID:24763279 | (1->4)-beta-D-glucan | multiple interactions | ISO | Rpl30 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RPL30 mRNA | CTD | PMID:36331819 | 1,2-dimethylhydrazine | multiple interactions | ISO | Rpl30 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RPL30 mRNA | CTD | PMID:22206623 | 1-naphthyl isothiocyanate | increases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in increased expression of RPL30 mRNA | CTD | PMID:20551477 | 2,3',4,4',5-Pentachlorobiphenyl | increases expression | ISO | Rpl30 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:31388691 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Rpl30 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of RPL30 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of RPL30 mRNA | CTD | PMID:33387578 and PMID:34747641 | 2,4,6-tribromophenol | decreases expression | ISO | RPL30 (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:31675489 | 2-amino-14,16-dimethyloctadecan-3-ol | decreases expression | ISO | RPL30 (Homo sapiens) | 6480464 | 2-amino-14 and 16-dimethyloctadecan-3-ol results in decreased expression of RPL30 protein | CTD | PMID:32044396 | 2-hydroxypropanoic acid | increases expression | ISO | RPL30 (Homo sapiens) | 6480464 | Lactic Acid results in increased expression of RPL30 mRNA | CTD | PMID:30851411 | 4,4'-diaminodiphenylmethane | affects expression | ISO | Rpl30 (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane affects the expression of RPL30 mRNA | CTD | PMID:18648102 | 4,4'-sulfonyldiphenol | increases expression | ISO | RPL30 (Homo sapiens) | 6480464 | bisphenol S results in increased expression of RPL30 protein | CTD | PMID:34186270 | 4-hydroxyphenyl retinamide | increases expression | ISO | Rpl30 (Mus musculus) | 6480464 | Fenretinide results in increased expression of RPL30 mRNA | CTD | PMID:28973697 | all-trans-retinoic acid | increases expression | ISO | RPL30 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of RPL30 mRNA | CTD | PMID:23724009 | all-trans-retinoic acid | multiple interactions | ISO | Rpl30 (Mus musculus) | 6480464 | [bisphenol A co-treated with Tretinoin] results in increased expression of RPL30 mRNA | CTD | PMID:30951980 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of RPL30 mRNA | CTD | PMID:16483693 | ampicillin | multiple interactions | EXP | | 6480464 | [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of RPL30 protein | CTD | PMID:30545405 | aristolochic acid A | decreases expression | ISO | RPL30 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of RPL30 protein | CTD | PMID:33212167 | arsane | affects methylation | ISO | RPL30 (Homo sapiens) | 6480464 | Arsenic affects the methylation of RPL30 gene | CTD | PMID:25304211 | arsenic atom | affects methylation | ISO | RPL30 (Homo sapiens) | 6480464 | Arsenic affects the methylation of RPL30 gene | CTD | PMID:25304211 | arsenite(3-) | multiple interactions | ISO | RPL30 (Homo sapiens) | 6480464 | arsenite promotes the reaction [G3BP1 protein binds to RPL30 mRNA] | CTD | PMID:32406909 | arsenous acid | decreases expression | ISO | RPL30 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of RPL30 protein | CTD | PMID:25419056 | benzatropine | increases expression | ISO | RPL30 (Homo sapiens) | 6480464 | Benztropine results in increased expression of RPL30 protein | CTD | PMID:34122009 | benzo[a]pyrene | multiple interactions | ISO | Rpl30 (Mus musculus) | 6480464 | AHR protein affects the reaction [Benzo(a)pyrene affects the expression of RPL30 mRNA] | CTD | PMID:22228805 | benzo[a]pyrene | decreases methylation | ISO | RPL30 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of RPL30 promoter | CTD | PMID:27901495 | benzo[a]pyrene | increases expression | ISO | Rpl30 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of RPL30 mRNA | CTD | PMID:22228805 | beryllium sulfate | increases expression | ISO | RPL30 (Homo sapiens) | 6480464 | beryllium sulfate results in increased expression of RPL30 mRNA | CTD | PMID:16314022 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of RPL30 mRNA and bisphenol A results in increased expression of RPL30 protein | CTD | PMID:25181051 and PMID:32145629 | bisphenol A | decreases expression | ISO | RPL30 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of RPL30 protein | CTD | PMID:31675489 more ... | bisphenol A | increases methylation | ISO | RPL30 (Homo sapiens) | 6480464 | bisphenol A results in increased methylation of RPL30 gene | CTD | PMID:31601247 | bisphenol A | affects expression | ISO | RPL30 (Homo sapiens) | 6480464 | bisphenol A affects the expression of RPL30 mRNA | CTD | PMID:30903817 | bisphenol A | multiple interactions | ISO | Rpl30 (Mus musculus) | 6480464 | [bisphenol A co-treated with Tretinoin] results in increased expression of RPL30 mRNA | CTD | PMID:30951980 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of RPL30 mRNA | CTD | PMID:30903817 | Bisphenol B | increases expression | ISO | RPL30 (Homo sapiens) | 6480464 | bisphenol B results in increased expression of RPL30 protein | CTD | PMID:34186270 | cannabidiol | increases expression | ISO | RPL30 (Homo sapiens) | 6480464 | Cannabidiol results in increased expression of RPL30 protein | CTD | PMID:34122009 | carbon nanotube | increases expression | ISO | Rpl30 (Mus musculus) | 6480464 | Nanotubes and Carbon results in increased expression of RPL30 mRNA | CTD | PMID:25554681 | chloropicrin | decreases expression | ISO | RPL30 (Homo sapiens) | 6480464 | chloropicrin results in decreased expression of RPL30 mRNA | CTD | PMID:26352163 | chlorpyrifos | increases expression | ISO | Rpl30 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of RPL30 mRNA | CTD | PMID:37019170 | choline | multiple interactions | ISO | Rpl30 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of RPL30 gene | CTD | PMID:20938992 | chromium(6+) | affects expression | ISO | Rpl30 (Mus musculus) | 6480464 | chromium hexavalent ion affects the expression of RPL30 mRNA | CTD | PMID:28472532 | clofibrate | increases expression | ISO | Rpl30 (Mus musculus) | 6480464 | Clofibrate results in increased expression of RPL30 mRNA | CTD | PMID:17585979 | clozapine | increases expression | ISO | RPL30 (Homo sapiens) | 6480464 | Clozapine results in increased expression of RPL30 protein | CTD | PMID:34122009 | coumarin | decreases phosphorylation | ISO | RPL30 (Homo sapiens) | 6480464 | coumarin results in decreased phosphorylation of RPL30 protein | CTD | PMID:35688186 | cyclosporin A | increases expression | ISO | RPL30 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of RPL30 mRNA | CTD | PMID:20106945 | diarsenic trioxide | decreases expression | ISO | RPL30 (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of RPL30 protein | CTD | PMID:25419056 | dichloroacetic acid | increases expression | ISO | Rpl30 (Mus musculus) | 6480464 | Dichloroacetic Acid results in increased expression of RPL30 mRNA | CTD | PMID:28962523 | dicrotophos | decreases expression | ISO | RPL30 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of RPL30 mRNA | CTD | PMID:28302478 | disodium selenite | increases expression | ISO | RPL30 (Homo sapiens) | 6480464 | Sodium Selenite results in increased expression of RPL30 mRNA | CTD | PMID:18175754 | enzyme inhibitor | multiple interactions | ISO | RPL30 (Homo sapiens) | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of RPL30 protein | CTD | PMID:23301498 | ethanol | affects splicing | ISO | Rpl30 (Mus musculus) | 6480464 | Ethanol affects the splicing of RPL30 mRNA | CTD | PMID:30319688 | fenthion | increases expression | ISO | Rpl30 (Mus musculus) | 6480464 | Fenthion results in increased expression of RPL30 mRNA | CTD | PMID:34813904 | flavonoids | decreases expression | EXP | | 6480464 | Flavonoids results in decreased expression of RPL30 mRNA | CTD | PMID:18035473 | folic acid | multiple interactions | ISO | Rpl30 (Mus musculus) | 6480464 | [1 more ... | CTD | PMID:20938992 and PMID:22206623 | folic acid | decreases expression | ISO | Rpl30 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of RPL30 mRNA | CTD | PMID:25629700 | FR900359 | affects phosphorylation | ISO | RPL30 (Homo sapiens) | 6480464 | FR900359 affects the phosphorylation of RPL30 protein | CTD | PMID:37730182 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of RPL30 mRNA | CTD | PMID:22061828 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of RPL30 mRNA | CTD | PMID:33387578 | gentamycin | multiple interactions | EXP | | 6480464 | [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of RPL30 protein | CTD | PMID:30545405 | glyphosate | affects expression | ISO | Rpl30 (Mus musculus) | 6480464 | Glyphosate affects the expression of RPL30 protein | CTD | PMID:20045496 | glyphosate | increases expression | EXP | | 6480464 | Glyphosate results in increased expression of RPL30 mRNA | CTD | PMID:26302742 | haloperidol | increases expression | ISO | RPL30 (Homo sapiens) | 6480464 | Haloperidol results in increased expression of RPL30 protein | CTD | PMID:34122009 | ivermectin | decreases expression | ISO | RPL30 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of RPL30 protein | CTD | PMID:32959892 | L-methionine | multiple interactions | ISO | Rpl30 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of RPL30 gene | CTD | PMID:20938992 | lipopolysaccharide | multiple interactions | ISO | RPL30 (Homo sapiens) | 6480464 | [NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of RPL30 mRNA | CTD | PMID:35877022 | methamphetamine | decreases expression | EXP | | 6480464 | Methamphetamine results in decreased expression of RPL30 mRNA | CTD | PMID:15644446 | metronidazole | multiple interactions | EXP | | 6480464 | [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of RPL30 protein | CTD | PMID:30545405 | neomycin | multiple interactions | EXP | | 6480464 | [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of RPL30 protein | CTD | PMID:30545405 | nickel subsulfide | increases expression | EXP | | 6480464 | nickel subsulfide results in increased expression of RPL30 mRNA | CTD | PMID:21086188 | paracetamol | affects expression | ISO | Rpl30 (Mus musculus) | 6480464 | Acetaminophen affects the expression of RPL30 mRNA | CTD | PMID:17562736 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Rpl30 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RPL30 mRNA | CTD | PMID:36331819 | rac-lactic acid | increases expression | ISO | RPL30 (Homo sapiens) | 6480464 | Lactic Acid results in increased expression of RPL30 mRNA | CTD | PMID:30851411 | rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of RPL30 protein | CTD | PMID:35544339 | SB 431542 | multiple interactions | ISO | RPL30 (Homo sapiens) | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of RPL30 protein | CTD | PMID:37664457 | silicon dioxide | decreases expression | ISO | Rpl30 (Mus musculus) | 6480464 | Silicon Dioxide results in decreased expression of RPL30 mRNA | CTD | PMID:19073995 | sodium arsenite | decreases expression | ISO | RPL30 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of RPL30 protein | CTD | PMID:30528433 | succimer | multiple interactions | ISO | Rpl30 (Mus musculus) | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RPL30 mRNA | CTD | PMID:21641980 | testosterone enanthate | affects expression | ISO | RPL30 (Homo sapiens) | 6480464 | testosterone enanthate affects the expression of RPL30 mRNA | CTD | PMID:17440010 | tungsten | increases expression | ISO | Rpl30 (Mus musculus) | 6480464 | Tungsten results in increased expression of RPL30 mRNA | CTD | PMID:30912803 | valproic acid | affects expression | ISO | RPL30 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of RPL30 mRNA | CTD | PMID:25979313 | vancomycin | multiple interactions | EXP | | 6480464 | [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of RPL30 protein | CTD | PMID:30545405 | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of RPL30 mRNA | CTD | PMID:23034163 | |